Experienced drug users assess the relative harms and benefits of drugs: a web-based survey
This survey study (n=93) investigated the subjective harms and benefits of eleven drugs as reported by experienced drug users. Alcohol and tobacco were ranked as the most harmful, MDMA, LSD, and psilocybin as some of the least harmful drugs.
Authors
- Robin Carhart-Harris
- David Nutt
Published
Abstract
A web-based survey was used to consult the opinions of experienced drug users on matters related to drug harms. We identified a rare sample of 93 drug users with personal experience with 11 different illicit drugs that are widely used in the UK. Asked to assess the relative harms of these drugs, they ranked alcohol and tobacco as the most harmful, and three “Class A” drugs (MDMA, LSD, and psilocybin) and one class B (cannabis) were ranked as the four least harmful drugs. When asked to assess the relative potential for benefit of the 11 drugs, MDMA, LSD, psilocybin, and cannabis were ranked in the top four; and when asked why these drugs are beneficial, rather than simply report hedonic properties, they referred to potential therapeutic applications (e.g., as tools to assist psychotherapy). These results provide a useful insight into the opinions of experienced drug users on a subject about which they have a rare and intimate knowledge.
Research Summary of 'Experienced drug users assess the relative harms and benefits of drugs: a web-based survey'
Introduction
Earlier expert-led efforts to rank the harms of drugs have used Delphic or multicriteria approaches and found poor correspondence between expert assessments and existing legal classifications. Those studies typically engaged psychiatrists and other drug experts and produced a harm matrix that weighted physical harm, dependence, and social harm, but they did not directly consult experienced drug users despite users having intimate knowledge of drug effects and harms. Lester and colleagues set out to fill that gap by collecting the opinions of highly experienced drug users about the relative harms and benefits of a range of commonly used illicit substances, together with views on how each substance should be classified under the UK Misuse of Drugs Act and which information sources most influence perceptions of harm. The study therefore aims to compare user-derived rankings with prior expert assessments and to capture qualitative reasons why particular drugs are seen as harmful or beneficial.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Study Details
- Study Typeindividual
- Journal
- Compounds
- Topic
- Authors
- APA Citation
Carhart-Harris, R. L., & Nutt, D. J. (2013). Experienced drug users assess the relative harms and benefits of drugs: a web-based survey. Journal of Psychoactive Drugs, 45(4), 322-328. https://doi.org/10.1080/02791072.2013.825034
References (1)
Papers cited by this study that are also in Blossom
Grob, C. S., Danforth, A. L., Chopra, G. S. et al. · JAMA Psychiatry (2011)
Cited By (12)
Papers in Blossom that reference this study
Brasher, T., Rosen, D., Spinella, M. · International Journal of Wellbeing (2023)
Kopra, E., Ferris, J. A., Winstock, A. R. et al. · Journal of Psychopharmacology (2022)
Johnson, M. W., Griffiths, R. R., Hendricks, P. S. et al. · Neuropharmacology (2018)
Rucker, J., Iliff, J., Nutt, D. J. · Neuropharmacology (2017)
Carhart-Harris, R. L., Bolstridge, &. M., Day, C. M. J. et al. · Psychopharmacology (2017)
Stroud, J., Freeman, T. P., Leech, R. et al. · Psychopharmacology (2017)
Hendricks, P. S., Crawford, M. S., Cropsey, K. L. et al. · Journal of Psychopharmacology (2017)
Carhart-Harris, R. L., Nutt, D. J. · Journal of Psychopharmacology (2017)
Carhart-Harris, R. L., Goodwin, G. M. · Neuropsychopharmacology (2017)
Carbonaro, T. M., Bradstreet, M. P., Barrett, F. S. et al. · Journal of Psychopharmacology (2016)
Show all 12 papersShow fewer
Garcia-Romeu, A., Kersgaard, B., Addy, P. H. · Experimental and Clinical Psychopharmacology (2016)
Tófoli, L. F., De Araujo, D. B. · International Review of Neurobiology (2016)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.